Surface display of Gaussia princeps luciferase allows sensitive fungal pathogen detection during cutaneous aspergillosis

Virulence

Volumn 3, Issue 1, 2012, Pages 51-61

  Donat, Stefanie ^a,b   Hasenberg, Mike ^c,d   Schäfer, Tina ^a   Ohlsen, Knut ^a   Gunzer, Matthias ^c,d   Einsele, Hermann ^b   Löffler, Jürgen ^b   Beilhack, Andreas ^b   Krappmann, Sven ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Antifungal therapy; Aspergillus fumigatus; Bioluminescence; Biophotonic imaging; Cutaneous aspergillosis

Indexed keywords

ANTIFUNGAL AGENT; LUCIFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BIOLUMINESCENCE; CUTANEOUS ASPERGILLOSIS; DERMATOMYCOSIS; DISEASE MODEL; FUNGUS; HOST PATHOGEN INTERACTION; MOLECULAR IMAGING; MOUSE; NEUTROPENIA; NON INVASIVE PROCEDURE; NONHUMAN; PHOTON; TREATMENT RESPONSE; ANIMAL; BAGG ALBINO MOUSE; CELL TRACKING; COPEPOD; ENZYMOLOGY; EVALUATION; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MICROBIOLOGY; PHYSIOLOGY;

ASPERGILLUS FUMIGATUS; GAUSSIA PRINCEPS (T. SCOTT, 1894); MUS;

ANIMALS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CELL TRACKING; COPEPODA; FEMALE; GENE EXPRESSION; HUMANS; LUCIFERASES; MICE; MICE, INBRED BALB C;

EID: 84858273575     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.3.1.18799     Document Type: Article

References (38)

1. McNeil MM, Nash SL, Hajjeh RA, Phelan MA, Conn LA, Plikaytis BD, et al. Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis 2001; 33:641-647. PMID: 11486286; http://dx.doi.org/10.1086/322606
2. Warnock DW. Fungal diseases: an evolving public health challenge. Med Mycol 2006; 44:697-705. PMID:17127626; http://dx.doi.org/10.1080/13693780601009493
3. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34:7-14. PMID:11731939; http://dx.doi.org/10.1086/323335
4. Talbot GH, Bradley J, Edwards JE, Jr., Gilbert D, Scheld M, Bartlett JG. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 2006; 42:657-668. PMID:16447111; http://dx.doi.org/10.1086/499819
5. Warnock DW. Trends in the epidemiology of invasive fungal infections. Nihon Ishinkin Gakkai zasshi 2007; 48:1-12. PMID:17287717; http://dx.doi.org/10.3314/jjmm.48.1
6. Burgos A, Zaoutis TE, Dvorak CC, Hoffman JA, Knapp KM, Nania JJ, et al. Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases. Pediatrics 2008; 121:e1286-e1294. PMID:18450871; http://dx.doi.org/10.1542/peds.2007-2117
7. Patterson TF, Kirkpatrick WR, White M, Hiemenz JW, Wingard JR, Dupont B, et al. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine 2000; 79:250-260. PMID:10941354; http://dx.doi.org/10.1097/00005792-200007000-00006
8. Etienne KA, Subudhi CP, Chadwick PR, Settle P, Moise J, Magill SS, et al. Investigation of a cluster of cutaneous aspergillosis in a neonatal intensive care unit. J Hosp Infect 2011. In press. PMID:21840084; http://dx.doi.org/10.1016/j.jhin.2011.06.012
9. Murray CK, Loo FL, Hospenthal DR, Cancio LC, Jones JA, Kim SH, et al. Incidence of systemic fungal infection and related mortality following severe burns. Burns 2008; 34:1108-1112. PMID:18691821; http://dx.doi.org/10.1016/j.burns.2008.04.007
10. van Burik JA, Colven R, Spach DH. Cutaneous aspergillosis. J Clin Microbiol 1998; 36:3115-3121. PMID:9774549
11. Walsh TJ. Primary cutaneous aspergillosis-an emerging infection among immunocompromised patients. Clin Infect Dis 1998; 27:453-457. PMID:9770139; http://dx.doi.org/10.1086/514718
12. Zaas AK, Steinbach WJ. Mammalian models of aspergillosis. In: Goldman GH, Osmani SA, eds. The Aspergilli: Genomics, Medical Aspects, Biotechnology, and Research Methods. Boca Raton: CRC Press, 2007:401-412.
13. Ben-Ami R, Lewis RE, Leventakos K, Latgé JP, Kontoyiannis DP. Cutaneous model of invasive aspergillosis. Antimicrob Agents Chemother 2010; 54:1848-1854. PMID:20145078; http://dx.doi.org/10.1128/AAC.01504-09
14. Andreu N, Zelmer A, Wiles S. Noninvasive biophotonic imaging for studies of infectious disease. FEMS Microbiol Rev 2011; 35:360-394. PMID:20955395; http://dx.doi.org/10.1111/j.1574-6976.2010.00252.x
15. Contag CH, Contag PR, Mullins JI, Spilman SD, Stevenson DK, Benaron DA. Photonic detection of bacterial pathogens in living hosts. Mol Microbiol 1995; 18:593-603. PMID:8817482; http://dx.doi.org/10.1111/j.1365-2958.1995.mmi_18040593.x
16. Hutchens M, Luker GD. Applications of bioluminescence imaging to the study of infectious diseases. Cell Microbiol 2007; 9:2315-2322. PMID:17587328; http://dx.doi.org/10.1111/j.1462-5822.2007.00995.x
17. Zinn KR, Chaudhuri TR, Szafran AA, O'Quinn D, Weaver C, Dugger K, et al. Noninvasive bioluminescence imaging in small animals. ILAR J 2008; 49:103-115. PMID:18172337
18. d'Enfert C, Vecchiarelli A, Brown AJ. Bioluminescent fungi for real-time monitoring of fungal infections. Virulence 2010; 1:174-176. PMID:21178436; http://dx.doi.org/10.4161/viru.1.3.11119
19. Brock M, Jouvion G, Droin-Bergere S, Dussurget O, Nicola MA, Ibrahim-Granet O. Bioluminescent Aspergillus fumigatus, a new tool for drug efficiency testing and in vivo monitoring of invasive aspergillosis. Appl Environ Microbiol 2008; 74:7023-7035. PMID: 18820063; http://dx.doi.org/10.1128/AEM.01288-08
20. Ibrahim-Granet O, Jouvion G, Hohl TM, Droin-Bergere S, Philippart F, Kim OY, et al. In vivo bioluminescence imaging and histopathopathologic analysis reveal distinct roles for resident and recruited immune effector cells in defense against invasive aspergillosis. BMC Microbiol 2010; 10:105. PMID: 20377900; http://dx.doi.org/10.1186/1471-2180-10-105
21. Enjalbert B, Rachini A, Vediyappan G, Pietrella D, Spaccapelo R, Vecchiarelli A, et al. A multifunctional, synthetic Gaussia princeps luciferase reporter for live imaging of Candida albicans infections. Infect Immun 2009; 77:4847-4858. PMID:19687206; http://dx.doi.org/10.1128/IAI.00223-09
22. Tannous BA. Gaussia luciferase reporter assay for monitoring biological processes in culture and in vivo. Nat Protoc 2009; 4:582-591. PMID:19373229; http://dx.doi.org/10.1038/nprot.2009.28
23. Hama S, Tamalampudi S, Shindo N, Numata T, Yamaji H, Fukuda H, et al. Role of N-terminal 28-amino-acid region of Rhizopus oryzae lipase in directing proteins to secretory pathway of Aspergillus oryzae. Appl Microbiol Biotechnol 2008; 79:1009-1018. PMID: 18496686; http://dx.doi.org/10.1007/s00253-008-1502-6
24. Adachi T, Ito J, Kawata K, Kaya M, Ishida H, Sahara H, et al. Construction of an Aspergillus oryzae cellsurface display system using a putative GPI-anchored protein. Appl Microbiol Biotechnol 2008; 81:711-719. PMID:18813924; http://dx.doi.org/10.1007/s00253-008-1687-8
25. Szewczyk E, Krappmann S. Conserved regulators of mating are essential for Aspergillus fumigatus cleistothecium formation. Eukaryot Cell 2010; 9:774-783. PMID: 20348388; http://dx.doi.org/10.1128/EC.00375-09
26. Wagener J, Echtenacher B, Rohde M, Kotz A, Krappmann S, Heesemann J, et al. The putative a-1,2-mannosyltransferase AfMnt1 of the opportunistic fungal pathogen Aspergillus fumigatus is required for cell wall stability and full virulence. Eukaryot Cell 2008; 7:1661-1673. PMID:18708564; http://dx.doi.org/10.1128/EC.00221-08
27. Tannous BA, Kim DE, Fernandez JL, Weissleder R, Breakefield XO. Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther 2005; 11:435-443. PMID:15727940; http://dx.doi.org/10.1016/j.ymthe.2004.10.016
28. Smith JM, Tang CM, Van Noorden S, Holden DW. Virulence of Aspergillus fumigatus double mutants lacking restriction and an alkaline protease in a lowdose model of invasive pulmonary aspergillosis. Infect Immun 1994; 62:5247-5254. PMID:7960101
29. Woodcock DM, Crowther PJ, Doherty J, Jefferson S, DeCruz E, Noyer-Weidner M, et al. Quantitative evaluation of Escherichia coli host strains for tolerance to cytosine methylation in plasmid and phage recombinants. Nucleic Acids Res 1989; 17:3469-3478. PMID: 2657660; http://dx.doi.org/10.1093/nar/17.9.3469
30. Hearn VM, Mackenzie DW. Mycelial antigens from two strains of Aspergillus fumigatus: an analysis by twodimensional immunoelectrophoresis. Mykosen 1980; 23:549-562. PMID:6160400
31. Käfer E. Meiotic and mitotic recombination in Aspergillus and its chromosomal aberrations. Adv Genet 1977; 19:33-131. PMID:327767; http://dx.doi.org/10.1016/S0065-2660(08)60245-X
32. Kubodera T, Yamashita N, Nishimura A. Pyrithiamine resistance gene (ptrA) of Aspergillus oryzae: cloning, characterization and application as a dominant selectable marker for transformation. Biosci Biotechnol Biochem 2000; 64:1416-1421. PMID:10945258; http://dx.doi.org/10.1271/bbb.64.1416
33. Hanahan D, Jessee J, Bloom FR. Plasmid transformation of Escherichia coli and other bacteria. Methods Enzymol 1991; 204:63-113. PMID:1943786; http://dx.doi.org/10.1016/0076-6879(91)04006-A
34. Punt PJ, van den Hondel CA. Transformation of filamentous fungi based on hygromycin B and phleomycin resistance markers. Methods Enzymol 1992; 216:447-457. PMID:1479914; http://dx.doi.org/10.1016/0076-6879(92)16041-H
35. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
36. Momany M. Cell biology of the duplication cycle in fungi. In: Talbot NJ, ed. Molecular and cellular biology of filamentous fungi: a practical approach. Oxford: Oxford University Press, 2001.
37. Oakley BR, Osmani SA. Cell-cycle analysis using the filamentous fungus Aspergillus nidulans. In: Fantes P, Brooks R, eds. The cell cycle: a practical approach. Oxford: Oxford University Press, 1993.
38. Hernáez ML, Ximenez-Embun P, Martinez-Gomariz M, Gutierrez-Blazquez MD, Nombela C, Gil C. Identification of Candida albicans exposed surface proteins in vivo by a rapid proteomic approach. J Proteomics 2010; 73:1404-1409. PMID:20167299; http://dx.doi.org/10.1016/j.jprot.2010.02.008